Studio Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-500
| Closed | -$30.5K | – | 184 |
|
|
2025
Q1 | $30.5K | Hold |
500
| – | – | 0.01% | 219 |
|
|
2024
Q4 | $28.3K | Hold |
500
| – | – | 0.01% | 216 |
|
|
2024
Q3 | $25.9K | Sell |
500
-392
| -44% | -$20.3K | 0.01% | 215 |
|
|
2024
Q2 | $37K | Hold |
892
| – | – | 0.01% | 192 |
|
|
2024
Q1 | $48.4K | Hold |
892
| – | – | 0.01% | 185 |
|
|
2023
Q4 | $45.8K | Hold |
892
| – | – | 0.01% | 178 |
|
|
2023
Q3 | $51.8K | Hold |
892
| – | – | 0.01% | 169 |
|
|
2023
Q2 | $57K | Hold |
892
| – | – | 0.02% | 161 |
|
|
2023
Q1 | $61.8K | Buy |
892
+392
| +78% | +$27.2K | 0.02% | 147 |
|
|
2022
Q4 | $36K | Hold |
500
| – | – | 0.01% | 140 |
|
|
2022
Q3 | $35.5K | Hold |
500
| – | – | 0.01% | 140 |
|
|
2022
Q2 | $39K | Buy |
+500
| New | +$39K | 0.01% | 144 |
|